TriSalus Life Sciences (TLSIW) Asset Utilization Ratio (2023 - 2026)

TriSalus Life Sciences (TLSIW) has 4 years of Asset Utilization Ratio data on file, last reported at 0.84 in Q1 2026.

• For the quarter ending Q1 2026, Asset Utilization Ratio fell 30.91% year-over-year to 0.84; the trailing twelve-month figure through Mar 2026 stood at 0.84 (down 30.91% YoY), and the FY2025 full-year result was 1.52, up 25.65% from the prior year.
• Asset Utilization Ratio for Q1 2026 stood at 0.84, down from 1.26 in the prior quarter.
• Across five years, Asset Utilization Ratio topped out at 1.26 in Q4 2025 and bottomed at 0.64 in Q4 2023.
• The 4-year median for Asset Utilization Ratio is 1.01 (2024), against an average of 0.97.
• The widest annual swing landed in 2024, when Asset Utilization Ratio surged 79.72%; it then tumbled 30.91% in 2026.
• A 4-year view of Asset Utilization Ratio shows it stood at 0.64 in 2023, then soared by 79.72% to 1.14 in 2024, then climbed by 9.94% to 1.26 in 2025, then plunged by 32.87% to 0.84 in 2026.
• The last three Asset Utilization Ratio figures came in at 0.84 (Q1 2026), 1.26 (Q4 2025), and 1.03 (Q3 2025), per Business Quant data.

Peer Comparison